Restless legs syndrome and periodic limb movement disorder

Medical Clinics of North America

Volumn 88, Issue 3, 2004, Pages 653-667

  Rama, Anil N ^a   Kushida, Clete A ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMANTADINE; AMFEBUTAMONE; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CABERGOLINE; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CLONIDINE; COMPTAN; ENDANTADINE; ENDOCODONE; ENTACAPONE; FOLIC ACID; GABAPENTIN; IRON; LEVODOPA; NALOXONE; OXYCODONE; PERGOLIDE; PERGOLIDE MESILATE; PRAMIPEXOLE; ROPINIROLE; SELEGILINE; SUPEUDOL; TEMAZEPAM; TRAMADOL; TRIAZOLAM;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ELECTROMYOGRAPHY; HEREDITY; HUMAN; IRON THERAPY; MOTOR DYSFUNCTION; PATHOPHYSIOLOGY; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; REVIEW; SLEEP;

ADRENERGIC AGONISTS; ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; HUMANS; LIFE STYLE; NARCOTICS; NOCTURNAL MYOCLONUS SYNDROME; RESTLESS LEGS SYNDROME;

EID: 1842840034     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.01.004     Document Type: Review

References (115)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 4:2003;101-119.
2. Freedom T., Merchut M.P. Arm restlessness as the initial symptom in restless legs syndrome. Arch Neurol. 60:2003;1013-1015.
3. Ondo W., Jankovic J. Restless legs syndrome: clinicoetiologic correlates. Neurology. 47:1996;1435-1441.
4. Wetter T.C., Stiasny K., Kohnen R., Oertel W.H., Trenkwalder C. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome. Mov Disord. 13:1998;820-824.
5. Rutkove S.B., Matheson J.K., Logigian E.L. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve. 19:1996;670-672.
6. Walters A.S., Wagner M., Hening W.A. Periodic limb movements as the initial manifestation of restless legs syndrome triggered by lumbosacral radiculopathy. Sleep. 19:1996;825-826.
7. O'Keeffe S.T., Gavin K., Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing. 23:1994;200-203.
8. Lee K.A., Zaffke M.E., Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J Womens Health Gend Based Med. 10:2001;335-341.
9. Yunus M.B., Aldag J.C. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 312:1996;1339.
10. Reynolds G., Blake D.R., Pall H.S., Williams A. Restless leg syndrome and rheumatoid arthritis. BMJ. 292:1986;659-660.
11. Picchietti D.L., Underwood D.J., Farris W.A., Walters A.S., Shah M.M., Dahl R.E., et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord. 14:1999;1000-1007.
12. Botez M.I., Lambert B. Folate deficiency and restless legs syndrome in pregnancy. N Engl J Med. 297:1977;670.
13. Gudbjomsson B., Broman J.E., Hetta J., Halgren R. Sleep disturbances in patients with primary Sjögren's syndrome. Br J Rheum. 32:1993;1072-1076.
14. Smith R.C. Relationship of periodic limb movements in sleep (nocturnal myoclonus) and the Babinski's sign. Sleep. 8:1985;239-243.
15. Stiasny K., Oertel W.H., Trenkwalder C. Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder. Sleep Med Rev. 6:2002;253-265.
16. Sforza E., Jouny C., Ibanez V. Time course of arousal response during periodic leg movements in patients with periodic leg movements and restless legs syndrome. Clin Neurophysiol. 114:2003;1116-1124.
17. Recording and scoring leg movements. The Atlas Task Force. Sleep. 16:1993;748-759.
18. American Sleep Disorders Association. The International Classification of Sleep Disorders: diagnostic and coding manual, revised. 1997;American Sleep Disorders Association, Rochester, MN.
19. Montplaisir J., Godbout R. Nocturnal sleep of narcoleptic patients: revisited. Sleep. 9:(1 Pt 2):1986;159-161.
20. Fry J.M., DiPhillipo M.A., Pressman M.R. Periodic leg movements in sleep following treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Chest. 96:1989;89-91.
21. Coleman R.M., Pollak C.P., Weitzman E.D. Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Ann Neurol. 8:1980;416-421.
22. Chervin R.D. Periodic leg movements and sleepiness in patients evaluated for sleep-disordered breathing. Am J Respir Crit Care Med. 164:(8 Pt 1):2001;1454-1458.
23. Mahowald M.W. Con: assessment of periodic leg movements is not an essential component of an overnight sleep study. Am J Respir Crit Care Med. 164:(8 Pt 1):2001;1340-1342.
24. Coleman R.M., Bliwise D.L., Sajben N., Bruyn L. de, Boomkamp A., Menn M.E., et al. Epidemiology of periodic movements during sleep. Guilleminault C., Lugaresi E. Sleep/wake disorders. natural history, epidemiology and long term evolution. 1988;217-229 Raven Press, New York.
25. Feinsilver S.H. Sleep in the elderly. What is normal? Clin Geriatr Med. 19:2003;177-188.
26. LaBan M.M., Viola S.L., Femminineo A.F., Taylor R.S. Restless legs syndrome associated with diminished cardiopulmonary compliance and lumbar spinal stenosis - a motor concomitant of "Vesper's curse. Arch Phys Med Rehabil. 71:(6):1990;384-388.
27. Konofal E., Lecendreux M., Bouvard M.P., Mouren-Simeoni M.C. High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: a video analysis. Psychiatry Clin Neurosci. 55:2001;97-103.
28. Picchietti D.L., England S.J., Walters A.S., Willis K., Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attention deficit hyperactivity disorder. J Child Neurol. 13:1998;588-594.
29. Baran A.S., Richert A.C., Douglas A.B., May W., Ansarin K. Change in periodic limb movement index during treatment of obstructive sleep apnea with continuous positive airway pressure. Sleep. 26:2003;717-720.
30. Exar E.N., Collop N.A. The association of upper airway resistance with periodic limb movements. Sleep. 24:2001;188-192.
31. Lavigne G.J., Montplaisier J.Y. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep. 17:1994;739-743.
32. Tan E.K., Seah A., See S.J., Lim E., Wong M.C., Koh K.K. Restless legs syndrome in an Asian population: a study in Singapore. Mov Disord. 16:2001;577-579.
33. Ohayon M.M., Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res. 53:2002;547-554.
34. Montplaisir J., Boucher S., Poirier G., Lavigne G., Lapierre O., Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 12:1997;61-65.
35. Trenkwalder C., Walters A.S., Hening W. Periodic limb movements and restless legs syndrome. Neurol Clin. 14:1996;629-650.
36. Bonati M.T., Ferini-Strambi L., Aridon P., Oldani A., Zucconi M., Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain. 126:(Pt 6):2003;1485-1492.
37. Winkelmann J., Muller-Myhsok B., Wittchen H.U., Hock B., Prager M., Pfister H., et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol. 52:2002;297-302.
38. Ondo W.G., Vuong K.D., Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology. 55:2000;1404-1406.
39. Ruottinen H.M., Partinen M., Hublin C., Bergman J., Haaparanta M., Solin O., et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology. 54:2000;502-504.
40. Michaud M., Soucy J.P., Chabli A., Lavigne G., Montplaisir J. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic limb movements in sleep. J Neurol. 249:2002;164-170.
41. Trenkwalder C., Hening W.A., Walters A.S., Campbell S.S., Rahman K., Chokroverty S. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome. Mov Disord. 14:1999;102-110.
42. Sowers J.R., Vlachakis N. Circadian variations in plasma dopamine levels in man. J Endocrinol Invest. 7:1984;3415.
43. Earley C.J., Connor J.R., Beard J.L., Malecki E.A., Epstein D.K., Allen R.P. Abnormalities in CSF concentrations of ferritin and transferring in restless legs syndrome. Neurology. 54:2000;1698-1700.
44. Allen R.P., Barker P.B., Wehrl F., Song H.K., Earley C.J. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 56:2001;263-265.
45. Connor J.R., Boyer P.J., Menzies S.L., Dellinger B., Allen R.P., Ondo W.G., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 61:2003;304-309.
46. Allen R.P., Mignot E., Ripley B., Nishino S., Earley C.J. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Neurology. 59:2002;639-641.
47. Bucher S.F., Seelos K.C., Oertel W.H., Reiser M., Trenkwalder C. Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol. 41:1997;639-645.
48. Barton JC, Wooten VD, Acton RT. Hemochromatosis and iron therapy of restless legs syndrome. 2001;2:249-51.
49. Ondo W., Tan E.K., Mansoor J. Rheumatologic serologies in secondary restless legs syndrome. Mov Disord. 1:2000;321-323.
50. Edinger J.D., Fins A.I., Sullivan R.J., Marsh G.R., Dailey D.S., Young M. Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder. Sleep. 19:1996;442-444.
51. Paulson G.W. Restless legs syndrome: how to provide symptom relief with drug and nondrug therapies. Geriatrics. 55:2000;35-38. 43-44, 47-48.
52. Aldrich M.S., Shipley J.E. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res. 17:1993;192-196.
53. Lutz E.G. Restless legs, anxiety, and caffeinism. J Clin Psychiatry. 39:1978;693-698.
54. Dorsey C.M., Lukas S.E., Cunningham S.L. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology. 14:1996;437-442.
55. Markkula J., Lauerma H. Mianserin and restless legs. Int Clin Psychopharmacol. 12:1997;53-58.
56. Hargrave R., Beckley D.J. Restless legs syndrome exacerbated by sertraline. Psychosomatics. 39:1998;177-178.
57. Paik I.H., Lee C., Choi B.M., Chae Y.L., Kim C.E. Mianserin-induced restless legs syndrome. Br J Psychiatry. 155:1989;415-417.
58. Agargun M.Y., Kara H., Ozbek H., Tombul T., Ozer O.A. Restless legs syndrome induced by mirtazapine. J Clin Psychiatry. 63:2002;1179.
59. Sanz-Fuentenebro F.J., Huidobro A., Tejadas-Rivas A. Restless legs syndrome and paroxetine. Acta Psychiatr Scand. 94:1996;482-484.
60. Kraus T., Schuld A., Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol. 19:1999;478-479.
61. Wetter T.C., Brunner J., Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry. 35:2002;109-111.
62. Morgan L.K. Letter: restless legs: precipitated by beta blockers, relieved by orphenadrine. Med J Aust. 2:1975;753.
63. Drake M.E. Restless legs with antiepileptic drug therapy. Clin Neurol Neurosurg. 90:1988;151-154.
64. Terao T., Terao M., Yoshimura R., Abe K. Restless legs syndrome induced by lithium. Biol Psychiatry. 30:1991;1167-1170.
65. Chen J.T., Garcia P.A., Alldredge B.K. Zonisamide-induced restless legs syndrome. Neurology. 60:2003;147.
66. Ohayon M.M., Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in general population. J Psychosom Res. 53:2002;547-554.
67. Mountfield J.A. Restless legs syndrome relieved by cessation of smoking. CMAJ. 133:1985;426-427.
68. Lavigne G.L., Lobbezoo F., Rompre P.H., Nielsen T.A., Montplaisir J. Cigarette smoking as a risk factor or an exacerbating factor for restless legs syndrome and sleep bruxism. Sleep. 20:1997;290-293.
69. Silber M.H., Richardson J.W. Multiple blood donations associated with iron deficiency in patients with restless legs syndrome. Mayo Clin Proc. 78:2003;52-54.
70. Sun E.R., Chen C.A., Ho G., Earley C.J., Allen R.P. Iron and the restless legs syndrome. Sleep. 21:1998;371-377.
71. Montplaisir J., Nicolas A., Denesle R., Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology. 52:1999;938-943.
72. Montplaisir J., Denesle R., Petit D. Pramipexole in the treatment of restless legs syndrome: a follow-up study. Eur J Neurol. 7:(Suppl 1):2000;27-31.
73. Ondo W. Ropinirole for restless legs syndrome. Mov Disord. 14:1999;138-140.
74. Ahmed I. Ropinirole in restless legs syndrome. Mo Med. 99:2002;500-501.
75. Saletu M., Anderer P., Saletu B., Hauer C., Mandl M., Oberndorfer S., et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology. 41:2000;190-199.
76. Estivill E., de la Fuente V. The use of ropinirole as a treatment for restless legs syndrome. Rev Neurol. 28:1999;962-963.
77. Wetter T.C., Stiasny K., Winkelmann J., Buhlinger A., Brandenburg U., Penzel T., et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology. 52:1999;944-950.
78. Staedt J., Hunerjarger H., Ruther E., Stoppe G. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). Long term follow up on pergolide. Short communication. J Neural Transm. 105:1998;265-268.
79. Staedt J., Wassmuth F., Ziemann U., Hajak G., Ruther E., Stoppe G. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-dopa. J Neural Transm. 104:1997;461-468.
80. Winkelmann J., Wetter T.C., Stiasny K., Oertel W.H., Trenkwalder C. Treatment of restless legs syndrome with pergolide-an open clinical trial. Mov Disord. 13:1998;566-569.
81. Walters A.S., Hening W.A., Kavey N., Chokroverty S., Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol. 24:1988;455-458.
82. Stiasny K., Robbecke J., Schuler P., Oertel W.H. Treatment of idiopathic restless legs syndrome (RLS) with the D2-agonist cabergoline: an open clinical trial. Sleep. 23:2000;349-354.
83. Trenkwalder C., Stiasny K., Pollmacher T., Wetter T., Schwarz J., Kohnen R., et al. L-Dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep. 18:1995;681-688.
84. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 19:1996;205-213.
85. Saletu M., Anderer P., Hogl B., Saletu-Zyhlarz G., Kunz A., Poewe W., et al. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with acombination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome. J Neural Transm. 110:2003;611-626.
86. Collado-Seidel V., Kazenwadel J., Wetter T.C., Kohnen R., Winkelmann J., Selzer R., et al. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms. Neurology. 52:1999;285-290.
87. Earley C.J., Allen R.P. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients. Sleep. 19:1996;801-810.
88. Allen R.P., Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep. 19:1996;205-213.
89. Boghen D., Lamothe L., Elie R., Godbout R., Montplaisir J. The treatment of the restless legs syndrome with clonazepam: a prospective controlled study. Can J Neurol Sci. 13:1986;245-247.
90. Mitler M.M., Browman C.P., Menn S.J., Gujavarty K., Timms R.M. Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep. 9:1986;385-392.
91. Horiguchi J., Inami Y., Sasaki A., Nishimatsu O.K., Sukegawa T. Periodic leg movements in sleep with restless legs syndrome: effect of clonazepam treatment. Jpn J Psychiatry Neurol. 46:1992;727-732.
92. Peled R., Lavie P. Double-blind evaluation of clonazepam on periodic leg movements in sleep. J Neurol Neurosurg Psychiatry. 50:1987;1679-1681.
93. Montagna P., Sassoli de Bianchi L., Zucconi M., Cirignotta F., Lugaresi E. Clonazepam and vibration in restless legs syndrome. Acta Neurol Scand. 69:1984;428-430.
94. Mitler M.M., Browman C.P., Menn S.J., Gujavarty K., Timms R.M. Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam. Sleep. 9:1986;385-392.
95. Doghramji K., Browman C.P., Gaddy J.R., Walsh J.K. Triazolam diminishes daytime sleepiness and sleep fragmentation in patients with periodic limb movements in sleep. J Clin Psychopharmacol. 11:1991;284-290.
96. Scharf M.B., Brown L., Hirschowitz J. Possible efficacy of alprazolam in restless legs syndrome. Hillside J Clin Psychiatry. 8:1986;214-223.
97. Wagner M.L., Walters A.S., Coleman R.G., Hening W.A., Grasing K., Chokroverty S. Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep. 19:1996;52-58.
98. Garcia-Borreguero D., Larrosa O., de la Llave Y., Verger K., Masramon X., Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology. 59:2002;1573-1579.
99. Happe S., Klosch G., Saletu B., Zeitholfer J. Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology. 57:2001;1717-1719.
100. Happe S., Sauter C., Klosch G., Saletu B., Zeitlhofer J. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology. 48:2003;82-86.
101. Telstad W., Sorensen O., Larsen S., Lillevold P.E., Stensrud P., Nyberg-Hansen R. Treatment of the restless legs syndrome with carbamazepine: a double blind study. BMJ. 288:1984;444-446.
102. Lundvall O., Abom P.E., Holm R. Carbamazepine in restless legs: a controlled pilot study. Eur J Clin Pharmacol. 25:1983;323-324.
103. Zucconi M., Coccagna G., Petronelli R., Gerardi R., Mondini S., Cirignotta F. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Funct Neurol. 4:1989;263-271.
104. Walters A.S., Wagner M.L., Hening W.A., Grasing K., Mills R., Chokroverty S., et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep. 16:1993;327-332.
105. Hening W.A., Walters A., Kavey N., Gidro-Frank S., Cote L., Fahn S. Dyskinesias while awake and periodic limb movements in sleep in restless legs syndrome: treatment with opioids. Neurology. 36:1986;1363-1366.
106. Walters A.S., Winkelmann J., Trenkwalder C., Fry J.M., Kataria V., Wagner M., et al. Long-term follow-up on restless legs syndrome patients treated with opiods. Mov Disord. 16:2001;1105-1109.
107. Evidente V.G., Adler C.H., Caviness J.N., Hentz J.G., Gwinn-Hardy K. Amantidine is beneficial in restless legs syndrome. Mov Disord. 15:2000;324-327.
108. Kapur N., Friedman R. Oral ketamine: a promising treatment for restless legs syndrome. Anesth Analg. 94:2002;1558-1559.
109. Nofzinger E.A., Fasiczka A., Berman S., Thase M.E. Bupropion SR reduces periodic limb movements associated with arousals from sleep in depressed patients with periodic limb movement disorder. J Clin Psychiatry. 61:2000;858-862.
110. Botez M.I. Folate deficiency and neurological disorders in adults. Med Hypotheses. 2:1976;135-140.
111. Lauerma H., Markkula J. Treatment of restless legs syndrome with tramadol: an open study. J Clin Psychiatry. 60:1999;241-244.
112. Grewal M., Hawa R., Shapiro C. Treatment of periodic limb movements in sleep with selegiline HCl. Mov Disord. 17:2002;398-401.
113. Sharif A.A. Entacapone in restless legs syndrome. Mov Disord. 17:2002;421.
114. Yasuda T., Nishimura A., Katsuki Y., Tsuji Y. Restless legs syndrome treated successfully by kidney transplantation: a case report. Clin Transpl. 46:(1):2002;114-117.
115. Jakobsoon B., Ruuth K. Successful treatment of restless legs syndrome with an implanted pump for intrathecal drug delivery. Acta Anaesthesiol Scand. 46:2002;114-117.